You are currently viewing a new version of our website. To view the old version click .
Proceedings
  • Abstract
  • Open Access

16 November 2017

Is the Dietary miR-193b a Novel Cell Cycle Arresting Source for Breast Carcinoma? †

and
Department of Medical Biology, School of Medicine, Suleyman Demirel University, Isparta 040900, Turkey
*
Author to whom correspondence should be addressed.
Presented at the 2nd International Conference on Natural Products for Cancer Prevention and Therapy, Kayseri, Turkey, 8–11 November 2017.
This article belongs to the Proceedings Proceedings of the 2nd International Conference on Natural Products for Cancer Prevention and Therapy

Abstract

There are many reasons that make the foods carcinogenic because of containing inorganic and organic molecules, such as nucleic acids, miRNA. Given the tumor suppressor or oncogenic effects of miRNAs, the dietary carcinogenic effect depends on the type of miRNA. The dietary miRNAs having tumor suppressor properties should be consumed to provide cancer protection and prevention. In this study, we aimed to show the regulatory role of miR-193b on key mediators related to cell cycle pathway in breast cancer cells. We evaluated both mRNA and protein expressions of Cyclin D1 and CDK4 in MCF-7, an estrogen receptor (ER) positive breast cancer cell, and MDA-MB-231, a triple-negative breast cancer cell. Based on our data, miR-193 caused to inhibit the cell cycle at G1 checkpoint, since the expressions of Cyclin D1 and CDK4 were markedly down-regulated at both the mRNA and protein levels in MCF-7 and MDA-MB-231 breast cancer cells after treatment with a 50 nM concentration for 72 h. These data suggest that miR-193b is a tumor suppressor in both ER positive and triple-negative breast cancer cells because it leads the cell cycle arrest at G1 checkpoint. The miR-193b rich foods might help to protect and prevent us from breast cancer.

Acknowledgment

This work was supported by TUBITAK (The Scientific and Technological Research Council of Turkey) Grant 114S501.

Conflicts of Interest

The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.